BiVictriX Therapeutics Company

BiVictriX is a drug discovery and development company. Their services include oncology, haematological malignancies, bispecific ADC therapeutics, biotherapeutics, immunotherapy, antibody research, and drug development.

Last Funding Type: Seed
Funding Status: Seed
Headquarters: Alderley Edge, Cheshire, United Kingdom
Founded Date: 2016
Last Funding Date: 08-19-2019
Employee Number: 1-10
Investors Number: 2
Industry: PharmTech